Ethyl Acetate → 4-{1-[2,5-Difluoro-4-(1-hydroxy-ethyl)-phenyl]-piperidin-4-ylideneaminooxy}-piperidine-1-carboxylic acid isopropyl ester
反応式
[BH4-].[Na+].[CH:3]([O:6][C:7]([N:9]1[CH2:14][CH2:13][CH:12]([O:15][N:16]=[C:17]2[CH2:22][CH2:21][N:20]([C:23]3[CH:28]=[C:27]([F:29])[C:26]([C:30](=[O:32])[CH3:31])=[CH:25][C:24]=3[F:33])[CH2:19][CH2:18]2)[CH2:11][CH2:10]1)=[O:8])([CH3:5])[CH3:4].C(OCC)(=O)C>CO.C([O-])(O)=O.[Na+]>[CH:3]([O:6][C:7]([N:9]1[CH2:14][CH2:13][CH:12]([O:15][N:16]=[C:17]2[CH2:18][CH2:19][N:20]([C:23]3[CH:28]=[C:27]([F:29])[C:26]([CH:30]([OH:32])[CH3:31])=[CH:25][C:24]=3[F:33])[CH2:21][CH2:22]2)[CH2:11][CH2:10]1)=[O:8])([CH3:5])[CH3:4]参加物
6
反応物 3
生成物 1
試薬・触媒・溶媒 2
実験手順
NaBH4 (0.15 g, 3.9 mmol) was added at 0° C. to a stirred solution of 50a (0.15 g, 0.34 mmol) in 5 mL of methanol. After 1 h, the mixture was diluted with 10 mL of saturated NaHCO3 and stirred for 20 minutes. The mixture was poured into ethyl acetate (25 mL), washed twice with brine (25 mL), dried and concentrated under vacuum. The residue was purified on an AS-H column (elution with 5% EtOH+0.1% triethylamine in hexane) to afford the 2 enantiomers of 4-{1-[2,5-difluoro-4-(1-hydroxy-ethyl)-phenyl]-piperidin-4-ylideneaminooxy}-piperidine-1-carboxylic acid isopropyl ester 50-1, LC-MS 422.2 (MFE-18), tR=6.45 (Method 2). EC50: 48 nM. 78 mg of the first enantiomer and 46 mg of the second enantiomer were obtained.
後処理
- washwashed twice with brine (25 mL)
- customdried
- concentrationconcentrated under vacuum
- customThe residue was purified on an AS-H column (elution with 5% EtOH+0.1% triethylamine in hexane)
出典と根拠
- ORDレコード
- ord-37e9fc74101c4b4899f526f39dd16d0c
- 出典データセット
- uspto-grants-2012_10
- 特許番号
- US08293729B2
反応ノート
読み込み中…